Absci Corporation (ABSI) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Absci Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.379 2025 Business Update and Financial and Operating Results conference 00:00:05.379 -- 00:00:10.647 call. At this time, all participants are in a listen-only mode. 00:00:10.647 -- 00:00:15.094 After the speaker presentation, there will be a question and answer session. 00:00:15.094 -- 00:00:19.921 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:19.921 -- 00:00:24.652 To remove yourself from the queue, you may press star 1 1 again. 00:00:24.652 -- 00:00:30.780 I would now like to hand the call over to Alex Khan, VP, Finance and Investor Relations. 00:00:30.780 -- 00:00:33.481 Please go ahead. 00:00:34.285 -- 00:00:38.991 Thank you. Earlier today, AdSci released financial and operating results for the quarter 00:00:38.991 -- 00:00:43.858 ended March 31, 2025. If you haven't received this news release, or if you would like 00:00:43.858 -- 00:00:48.164 to be added to the company's distribution list, please send an email to investors at 00:00:48.164 -- 00:00:49.610 AdSci.com. 00:00:49.610 -- 00:00:53.874 An archived webcast of this call will be available for replay on Abcide's investor relations 00:00:53.874 -- 00:00:56.575 website at investors.abcide.com 00:00:56.617 -- 00:00:59.540 for at least 90 days after this call. 00:00:59.540 -- 00:01:04.765 Joining me today are Sean McLean, Abcide's founder and CEO, and Zach Jonason, Chief Financial 00:01:04.765 -- 00:01:09.870 Officer and Chief Business Officer. Christian Stegman, Abcide's SVP of Drug Creation, 00:01:09.870 -- 00:01:13.814 will also join for Q&A following prepared remarks. 00:01:13.814 -- 00:01:17.003 Before we begin, I'd like to remind you that management will make statements during this 00:01:17.003 -- 00:01:20.647 call that are fo...